APA (7th ed.) Citation

YH, W., PL, D., H, Q., KX, Z., JW, G., DH, W., . . . K, L. (2026). Glycogen Synthase Kinase-3β Inhibition Ameliorates Synaptic and Mitochondrial Dysfunction in a Sporadic Alzheimer's Disease-Like Model. Molecular neurobiology, 63(1), . https://doi.org/10.1007/s12035-026-05970-1

Chicago Style (17th ed.) Citation

YH, Wang, Ding PL, Qin H, Zhang KX, Ge JW, Wu DH, Xie L, and Liang K. "Glycogen Synthase Kinase-3β Inhibition Ameliorates Synaptic and Mitochondrial Dysfunction in a Sporadic Alzheimer's Disease-Like Model." Molecular Neurobiology 63, no. 1 (2026). https://doi.org/10.1007/s12035-026-05970-1.

MLA (9th ed.) Citation

YH, Wang, et al. "Glycogen Synthase Kinase-3β Inhibition Ameliorates Synaptic and Mitochondrial Dysfunction in a Sporadic Alzheimer's Disease-Like Model." Molecular Neurobiology, vol. 63, no. 1, 2026, https://doi.org/10.1007/s12035-026-05970-1.